申请人:Eisai Co., Ltd.
公开号:US06750232B2
公开(公告)日:2004-06-15
A class of substituted compounds is described for use in treating inflammation and inflammation-related disorders. Compounds of particular interest are defined by formula (II), wherein R1 is selected from hydrido, halo, alkoxy, aryl, alkylthio, alkylamino, aralkoxy, azido and alkenyloxy; wherein R2 is selected from hydrido, cyano, hydroxyalkyl, haloalkyl, aminoalkyl, alkylaminoalkyl, alkylcarbonyloxyalkyl, aminocarbonyl and alkylcarbonylaminoalkyl; and wherein R5 and R6 are one more radicals independently selected from halo, alkylsulfonyl, aminosulfonyl, alkoxy and alkylthio; provided one of R5 and R6 is substituted with alkysulfonyl, aminosulfonyl, or haloalkylsulfonyl; or a pharmaceutically-acceptable salt thereof.
描述了一类用于治疗炎症和炎症相关疾病的取代化合物。特别感兴趣的化合物由式(II)定义,其中R1从氢基,卤素,烷氧基,芳基,烷基硫基,烷基氨基,芳基氧基,叠氮基和烯基氧基中选择;其中R2从氢基,氰基,羟基烷基,卤代烷基,氨基烷基,烷基氨基烷基,烷基羧酸酯氧基烷基,氨基羧酰基和烷基羧酰氨基烷基中选择;R5和R6分别是从卤素,烷基磺酰基,氨基磺酰基,烷氧基和烷基硫基中选择的一个或多个基团;只要R5和R6中的一个被取代为烷基磺酰基,氨基磺酰基或卤代烷基磺酰基;或其药学上可接受的盐。